Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-26

Clinical Trial Update: A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of food on the pharmacokinetics of TAK-536TCH Final Formulation Tablet in hypertension; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAK-536TCH Final Formulation Tablet

Snippet

Sponsor: Takeda | Conditions: Hypertension | Phase 1 | Status: COMPLETED | Results posted: 2016-04-26